Fagron Concepts

Patented delivery vehicles and branded pharmaceutical products Fagron UK is now the exclusive supplier of Humco's portfolio
SyrSpend® SF PH4 is Fagron's innovative oral suspension vehicle, compatible with a wide range of API's and superior to traditional suspension vehicles
An innovative solution for dermatological care.

News

Tuesday, July 31, 2018
Fagron acquires Humco, a leading developer, manufacturer and supplier of patented delivery vehicles and branded pharmaceutical products to over 45,000 pharmacies in the USA
Thursday, July 5, 2018
When preparing suspensions there are a number of sources from which you can access the active pharmaceutical ingredient or API.
Tuesday, December 19, 2017
A Fagron product has been approved for the NHS drug tariff in England and Wales.

News archive

Tuesday, July 31, 2018
Fagron acquires Humco, a leading developer, manufacturer and supplier of patented delivery vehicles and branded pharmaceutical products to over 45,000 pharmacies in the USA
Thursday, July 5, 2018
When preparing suspensions there are a number of sources from which you can access the active pharmaceutical ingredient or API.
Tuesday, December 19, 2017
A Fagron product has been approved for the NHS drug tariff in England and Wales.
Monday, November 20, 2017
The latest update of the SyrSpend® SF compatibility table.
Monday, October 2, 2017
Lollibase® is a dry powdered base for producing sugar-free hard candy type lollipops for oral administration and absorption across the buccal mucosa.
Wednesday, September 20, 2017
The NHS prescribes over £100million worth of Specials each year.
Wednesday, September 13, 2017
Fagron UK is renowned for high standards in product quality and documentation. We call it the ‘unique quality of Fagron’.
Wednesday, August 9, 2017
Happy Birthday to us!
Monday, August 7, 2017
Fagron can look back on a strong first half of 2017
Wednesday, July 26, 2017
The Pharmaceutical Journal warns about exposure to problem excipients for paediatrics.
Wednesday, June 14, 2017
Stability evaluation of 10 most commonly used API's compounded in SyrSpend® SF.
Friday, April 21, 2017
Fagron UK welcomes a new member to the team
Thursday, April 20, 2017
Hot off the press! Fagron turnover increases by 7.1% to € 109.9 million
Monday, March 27, 2017
New studies conducted on Syrspend SF
Monday, March 27, 2017
Read why SyrSpend® SF is a valuable alternative to capsules
Friday, February 17, 2017
Read this article about Parabens in oral pharmaceutical preparations
Thursday, February 16, 2017
Take a look at our latest compatibility table for Syrspend® SF PH4